These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11839362)

  • 21. Positron emission tomography: basic principles and applications in psychiatric research.
    Volkow ND; Brodie J; Bendriem B
    Ann N Y Acad Sci; 1991; 620():128-44. PubMed ID: 2035939
    [No Abstract]   [Full Text] [Related]  

  • 22. Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the magnetic resonance spectroscopy literature.
    Spencer AE; Uchida M; Kenworthy T; Keary CJ; Biederman J
    J Clin Psychiatry; 2014 Nov; 75(11):1226-41. PubMed ID: 25271988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress.
    Brady KT; Sinha R
    Am J Psychiatry; 2005 Aug; 162(8):1483-93. PubMed ID: 16055769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders.
    Soares JC; Krishnan KR; Keshavan MS
    Depression; 1996; 4(1):14-30. PubMed ID: 9160650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of magnetic resonance spectroscopy in geriatric mood disorders.
    Mathias LK; Monette PJ; Harper DG; Forester BP
    Int Rev Psychiatry; 2017 Dec; 29(6):597-617. PubMed ID: 29199890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy.
    Kegeles LS; Humaran TJ; Mann JJ
    Biol Psychiatry; 1998 Sep; 44(6):382-98. PubMed ID: 9777167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance spectroscopy in vivo: applications in neurological disorders.
    Arnold DL; De Stefano N
    Ital J Neurol Sci; 1997 Dec; 18(6):321-9. PubMed ID: 9494864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders.
    Lee MR; Denic A; Hinton DJ; Mishra PK; Choi DS; Pirko I; Rodriguez M; Macura SI
    Bioanalysis; 2012 Jul; 4(14):1787-804. PubMed ID: 22877223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of non-invasive neuroradiological methods in research of psychoactive drugs.
    Henigsberg N; Kovacić Z; Kalember P
    Psychiatr Danub; 2007 Sep; 19(3):234-7. PubMed ID: 17914326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NMR spectroscopic evaluation of cerebral metabolism in hydrocephalus: a review.
    Braun KP; Vandertop WP; Gooskens RH; Tulleken KA; Nicolay K
    Neurol Res; 2000 Jan; 22(1):51-64. PubMed ID: 10672581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance spectroscopy and schizophrenia: what have we learnt?
    Vance AL; Velakoulis D; Maruff P; Wood SJ; Desmond P; Pantelis C
    Aust N Z J Psychiatry; 2000 Feb; 34(1):14-25. PubMed ID: 11185927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New perspectives on techniques for the clinical psychiatrist: Brain stimulation, chronobiology and psychiatric brain imaging.
    Zanardi R; Barbini B; Rossini D; Bernasconi A; Fregni F; Padberg F; Rossi S; Wirz-Justice A; Terman M; Martiny K; Bersani G; Hariri AR; Pezawas L; Roiser JP; Bertolino A; Calabrese G; Magri L; Benedetti F; Pontiggia A; Malaguti A; Smeraldi E; Colombo C
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):627-37. PubMed ID: 19067998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear magnetic resonance spectroscopy: a review of neuropsychiatric applications.
    Passe TJ; Charles HC; Rajagopalan P; Krishnan KR
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):541-63. PubMed ID: 8588055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?
    Vion-Dury J; Meyerhoff DJ; Cozzone PJ; Weiner MW
    J Neurol; 1994 May; 241(6):354-71. PubMed ID: 7931430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of proton magnetic resonance spectroscopy findings in sport-related concussion.
    Gardner A; Iverson GL; Stanwell P
    J Neurotrauma; 2014 Jan; 31(1):1-18. PubMed ID: 24047225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton magnetic resonance spectroscopy in schizophrenia.
    Bertolino A; Weinberger DR
    Eur J Radiol; 1999 May; 30(2):132-41. PubMed ID: 10401594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical magnetic resonance spectroscopy: a critical evaluation.
    Lenkinski RE
    Invest Radiol; 1989 Dec; 24(12):1034-8. PubMed ID: 2606632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders.
    Dager SR; Steen RG
    Neuropsychopharmacology; 1992 Jun; 6(4):249-66. PubMed ID: 1632893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.